Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-649-0 | CAS number: 72403-66-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from March 10 to May 26, 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- EU method B.6 (Skin sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A LLNA study has not been conducted because adequate data from guinea pig Maximisation test study are already available.
Test material
- Reference substance name:
- Disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- EC Number:
- 276-649-0
- EC Name:
- Disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Cas Number:
- 72403-66-8
- Molecular formula:
- C36H21ClCrN7Na2O12S
- IUPAC Name:
- disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Test material form:
- other: solid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: CIBA-GEIGY Limited Animal Production 4332 Stein / Switzerland
- Weight at study initiation: between 358g to 413g
- Housing: individually in Macrolon cages (Type 3)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): from 19 to 25°C
- Humidity (%): 30 to 70%
- Photoperiod (hrs dark / hrs light): 12 hours dark / 12 hours light
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: Physiological saline; Bacto adjuvant; Vaseline
- Concentration / amount:
- 5% in induction phaseby intradermal injection
50% in induction phaseby epidermal application
50% in challenge phase
10% in rechallenge phase
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Physiological saline; Bacto adjuvant; Vaseline
- Concentration / amount:
- 5% in induction phaseby intradermal injection
50% in induction phaseby epidermal application
50% in challenge phase
10% in rechallenge phase
- No. of animals per dose:
- - for challenge, 5 males and 5 females per dose
- for rechallenge, 5 males and 5 females per dose - Details on study design:
- RANGE FINDING TESTS:
A. INDUCTION EXPOSURE INTRADERMAL
- Concentrations: 5 % in physiological saline (w/v)
B. INDUCTION EXPOSURE EPIDERMAL
- Concentrations: 5, 10, 20, 30, and 50% in physiological saline
MAIN STUDY
A. INDUCTION EXPOSURE INTRADERMAL
- No. of exposures: 3 pairs of intradermal injections
- Exposure period: from day 0 to day 8
- Test groups: 5 males and 5 females
- Control group: 5 males
- Site: left and right side of shaved neck
- Concentrations: 1 pair of injection of adjuvant/saline mixture 1:1 (v/v); 1 pair of injection of 5% substance in physiological saline (w/v); 1 pair of injection of 5% substance in the adjuvant/saline mixture (w/v)
MAIN STUDY
B. INDUCTION EXPOSURE EPIDERMAL
- Pretreatment: 10% sodium-laurylsulfate (open application) 24 hours
- Test groups: 5 males and 5 females
- Control group: 5 males
- Exposure period: 48 hours
- Site: neck
- Duration: from day 8 to day 22
- Concentrations: 50% of substance n physiological saline
A. CHALLENGE EXPOSURE
- No. of exposures: 1 on each flank (1 test substance and 1 vehicle only)
- Day(s) of challenge: from day 22 to day 25
- Exposure period: 24 hours
- Test groups: 5 males and 5 females
- Control group: 5 males
- Site: flanks
- Concentrations: 50% in physiological saline
- Evaluation (hr after challenge): 24 and 48 hours after removing the dressing
B. RECHALLENGE EXPOSURE
- No. of exposures: 1 on each flank (1 test substance and 1 vehicle only)
- Day(s) of challenge: from day 28 to day 30
- Exposure period: 24 hours
- Test groups: 5 males and 5 females
- Control group: 5 females
- Site: flanks
- Concentrations: 10% in physiological saline
- Evaluation (hr after challenge): 24 and 48 hours after removing the dressing - Challenge controls:
- 5 males for challenge
5 females for rechallenge - Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
Results and discussion
- Positive control results:
- Test and results fullfill the requirements for reliability check of the OECD Guideline 406 (page 2, paragraph 10 and 11).
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 8.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: control group
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: control group. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 10.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: control group
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control group. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 5.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 10%. No with. + reactions: 5.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- other: control group
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: other: control group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 10%. No with. + reactions: 7.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- other: control group
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: other: control group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 5.0.
Applicant's summary and conclusion
- Interpretation of results:
- other: Category 1B (indication of skin sensitising potential) based on CLP criteria
- Conclusions:
- Skin sensitising
- Executive summary:
Method
The study has been performed according to OECD guideline 406 and on Annex V, Part B of Council Directive 67/548/EEC.
The test has been performed in essence according to the original protocol of Magnusson and Kligman, on 5 male and 5 female guinea pigs in the test group and 5 male guinea pigs in the control group.
The animals were housed individually in Macrolon cages (Type 3), identified by individual ear tags, kept at a constant room temperature and a 12 hours light cycle day.
Test animals were initially exposed to the test substance by intradermal injection and epidermal application during a pretest phase. The test substance was selected at 5 % in physiological saline (w/v) for intradermal induction; after 7 days 5, 10, 20, 30 and 50 % of test substance in physiological saline were selected for an epidermal application. 50 % was the highest possible concentration of the test artcile in physiological saline. The tested concentrations did not induce erythema reactions. During the test procedure at day 0 the induction phase was performed with three pairs of intradermal injections (0.1 ml per injection) made simultaneously into the left and right side of the shaved neck of the test and control group animals. The injections of the test animals consisted of: - adjuvant/saline mixture 1:1 (v/v) - 5 % test article in physiological saline (w/v) - 5 % test article in the adjuvant/saline mixture (w/v).The injections of the control group consisted of: - adjuvant/saline mixture 1:1 (v/v) - adjuvant/saline mixture 1:1 (v/v) - physiological saline (w/v)At day 7 the application site of all animals was pretreated with 10 % sodium-laurylsulfate (open application) 24 hours prior to the epidermal induction application. At day 8 the substance at 50 % was incorporated in physiological saline and applied on a filterpaper patch to the neck of the animals (patch 2x4 cm; approx. 0.4 g per patch; occluded administration for 48 hours). The control group was treated with the physiological saline only. Following a resting period of 14 days (induction period), during which an immune response may develop, the animals were exposed to a challenge dose.The test and control group animals were tested on one flank with substance at 50 % in physiological saline and on the other flank with the vehicle only (patch 2x2 cm; approx. 0.2 g per patch; occluded administration for 24 hours). At day 28 after that the first challenge application caused reactions in 40 % of the animals of the control group, a second challenge, using a lower test article concentration and a new control group, was performed. The test and control group animals were tested on one flank with substance at 10 % in physiological saline and on the other flank with the vehicle only (patch 2x2 cm; approx. 0.2 g per patch; occluded administration for 24 hours).
Observations
After the first challenge application 80 % and 100 % of the animals of the test group and 40 % of the animals of the control showed skin reactions. After the second challenge application, using a lower test article concentration, 50 % and 70 % of the animals of the test group at 24 and 48 hours respectively were sensitised, and none of the animals of the new control group showed skin reactions after removing the dressings.
Conclusions
Skin sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.